Valuation: Beijing Science Sun Pharmaceutical Co., Ltd.

Market Cap 4.8B 707M 618M 568M 529M 1B 67.3B 1.02B 6.82B 2.65B 33.08B 2.65B 2.6B 114B P/E 2024
-50.1x
P/E 2025 353x
Enterprise Value 3.26B 480M 419M 385M 359M 681M 45.66B 692M 4.63B 1.8B 22.45B 1.8B 1.76B 77.35B EV / Sales 2024
4.33x
EV / Sales 2025 8.78x
Free-Float
42.82%
Yield 2024 *
-
Yield 2025 2.84%
1 day+2.36%
1 week+17.04%
Current month+4.73%
1 month+11.53%
3 months-11.70%
6 months-10.83%
Current year-5.86%
1 week 9.24
Extreme 9.24
10.2
1 month 7.77
Extreme 7.77
10.2
Current year 7.77
Extreme 7.77
12.9
1 year 7.77
Extreme 7.77
17.49
3 years 5.73
Extreme 5.73
17.49
5 years 5.73
Extreme 5.73
18.75
10 years 5.73
Extreme 5.73
28.08
Manager TitleAgeSince
Chief Executive Officer 62 2001-07-04
Director of Finance/CFO 45 2024-01-25
Director of Finance/CFO 57 2006-12-14
Director TitleAgeSince
Director/Board Member 48 2009-02-28
Chairman 62 2001-07-04
Director/Board Member 57 2005-09-30
Date Insider Type Main position Quantity % Market Cap.
01-19Sell

Director

780,000 0.3078%
01-14Sell

Director

2,301,800 0.9083%
01-13Sell

Director

2,445,200 0.9649%
Change 5-day change 1-year change 3-year change Capi.($)
+2.36%+17.04%-32.20%-2.92% 707M
+1.86%+0.48%+55.50%+160.66% 1,082B
+3.57%+3.29%+68.60%+61.56% 633B
+3.99%+3.05%+37.93%+89.70% 461B
-1.31%+1.37%+31.00%+23.05% 338B
-0.65%+0.38%+40.46%+38.96% 299B
-0.28%+0.84%+30.38%+45.16% 291B
-0.14%+3.62%-26.04%-39.70% 222B
+3.55%+4.41%+25.45%+65.64% 202B
+4.21%+2.65%+17.47%+69.95% 163B
Average +1.71%+4.31%+24.85%+51.21% 369.31B
Weighted average by Cap. +1.82%+5.43%+41.87%+81.98%

Financials

2024 2025
Net sales 416M 61.36M 53.64M 49.29M 45.95M 87.15M 5.84B 88.47M 592M 230M 2.87B 230M 225M 9.9B 405M 59.63M 52.12M 47.9M 44.65M 84.69M 5.68B 85.97M 575M 224M 2.79B 224M 219M 9.62B
Net income -68.85M -10.14M -8.87M -8.15M -7.6M -14.41M -966M -14.63M -97.84M -38.03M -475M -38.08M -37.26M -1.64B 14.57M 2.15M 1.88M 1.72M 1.61M 3.05M 204M 3.1M 20.7M 8.05M 100M 8.06M 7.88M 346M
Net Debt -1.57B -232M -202M -186M -173M -329M -22.05B -334M -2.23B -868M -10.84B -869M -850M -37.34B -1.54B -227M -199M -183M -170M -323M -21.63B -328M -2.19B -852M -10.63B -853M -835M -36.64B
Logo Beijing Science Sun Pharmaceutical Co., Ltd.
Beijing Science Sun Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of injectables. The Company's products are biological and biochemical drugs, covering several drug use areas: cardiovascular and cerebrovascular diseases, immune diseases (anti-tumor) and nervous system diseases. The main products of immunomodulatory drugs are Saisheng Bozhi glycopeptide injection and Saisheng deoxyribonucleotide sodium injection. The main products of cardiovascular and cerebrovascular drugs are Saibai fibrinolytic enzyme injection, myo-aminopeptide injection and myo-aminopeptide injection. The main product of nervous system drugs is Saidian monosialotetrahexosylganglioside sodium injection (GM-1). The Company mainly conducts its businesses in the domestic market.
Employees
489
Date Price Change Volume
26-07-03 CN¥9.960 +2.36% 16,402,805
26-07-02 CN¥9.730 -1.32% 18,418,200
26-07-01 CN¥9.860 +3.68% 22,495,400
26-06-30 CN¥9.510 -1.65% 19,801,091
26-06-29 CN¥9.670 +13.63% 27,527,038
  1. Stock Market
  2. Stocks
  3. 300485 Stock